ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-0827
    Keywords: Osteogenesis ; Osteoinduction ; Bone ; Matrix ; Cell
    Source: Springer Online Journal Archives 1860-2000
    Topics: Biology , Medicine , Physics
    Notes: Abstract Bone matrix demineralized in 0.6 N HCl at 2° for 24 h and implanted in muscle in allogeneic rats possesses consistently reproducible bone morphogenetic activity. Experiments on implants of matrix, obtained from donors injected with3H-tyrosine or3H-tryptophan, or Na35SO4, suggest that bone morphogenetic property is a protein or apart of a protein that is (1) insoluble in buffer solutions, pH 3.6 and 5.0; (2) degraded in buffer solutions at pH 7.4 by an endogenous sulfhydryl-group neutral proteinase; (3) digested by trypsin at 15° within 8 h without solubilization of the helical regions, possibly even without degradation of the nonhelical ends of the bone collagen molecule, and without any loss of the periodic ultrastructure of the collagen fibrils; (4) degraded or removed by 0.1 N NaOH at 2° within 24 h without solubilization of collagen; (5) biologically active even after nitration of tyrosyl groups with tetranitromethane. The release of only one-third of the radioactivity with loss of nearly all yield of new bone by limited tryptic digestion of3H-borohydride-reduced matrix indicates that the bone morphogenetic response is the function of a non-collagenous component. Autoradiographs of implants of matrix with non-collagenous proteins labelled with3H-tryptophan,3H-tyrosine, or both3H-tyrosine and3H-phenyl-alanine demonstrate random dissemination of the radioactive constituents and no evidence of local transfer of labelled proteins or soluble protein derivatives. Hypothetically, the bone morphogenetic response is controlled by an insoluble acidic bone morphogenetic protein or polypeptide (BMP) and a soluble neutral proteinase (BMP-ase) resembling trypsin in activity except functionally more specific for BMP. Firmly bound but separable from bone collagen, BMP is one of many short-lived morphogenetic substances appearing and disappearing throughout embryonic development and persisting in postfetal life. Where the BMP receptor resides and how it activates cell mechanisms of differential repression and derepression of such genes as code for osteogenesis is unknown.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Calcified tissue international 13 (1973), S. 197-215 
    ISSN: 1432-0827
    Keywords: Cortisone ; Metabolism ; Bone ; Thyroidectomy ; Calcitonin ; Osteoporosis
    Source: Springer Online Journal Archives 1860-2000
    Topics: Biology , Medicine , Physics
    Description / Table of Contents: Résumé Des lapins blancs néo-zélandais adultes sont répartis selon les groupes suivants: 1) témoin, sans traitement; 2) administration intramusculaire de 5 mg/kg de poids d'acétate de cortisone (CA); 3) thyroidectomie totale avec administration intramusculaire quotidienne de 25 μg de thyroxine; 4) thyroidectomie totale avec traitement à l'acétate de cortisone et de thyroxine, selon 2 et 3. Après 21, 28 et 35 jours de traitement, les fémurs et les corps vertébraux sont étudiés histologiquement, radiographiquement et par détermination du poids par unité devolume. Le calcium total, l'hydroxyproline et la rapport hexosamine-collagène sont déterminés dans les côtes, les fémurs et les corps vertébraux. La calcémie et la phosphorémie ont également été déterminées. Les animaux traités à la cortisone, non opérés ou thyroidectomisés, présentent une diminution de la masse osseuse: la diminution de tous les paramètres étudiés est surtout nette dans le groupe 4. Ces animaux étant surtout déficients en calcitonine, on peut penser que la décroissance de la masse osseuse est en rapport avec une telle déficience. Ces observations semblent indiquer que la calcitonine endogène contribue au maintien de la masse osseuse au cours des stades précoces d'hyperactivité surrénalienne, vraisemblablement induite par une hyperactivité de compensation de la parathyroide.
    Abstract: Zusammenfassung Erwachsene männliche weiße neuseeland-Kaninchen wurden in folgende Gruppen eingeteilt: 1) Kontrolle, keine Behandlung; 2) Cortison-Acetat (CA) 5 mg/kg Körpergewicht/Tag intramuskulär; 3) Totale Thyreoidektomie mit täglicher Ersatzgabe von 25 μg Thyroxin, i.m. wie bei Gruppe 2; 4) Totale Thyreoidektomie mit Thyroxingabe wie in Gruppe 3 und Ca-Gabe wie in Gruppe 2. Nach 21, 28 und 35 Behandlungstagen wurden die Femora und Wirbel histologisch, röntgenographisch und durch die Bestimmung des Gewichtes pro Volumeneinheit untersucht. Rippen, Femora und Wirbel wurden auf Gesamtcalcium, Hydroxyprolin und Hexosamin-Collagen-Verhältnis analysiert. Es wurden auch Serienbestimmungen von Calcium und anorganischem Phosphor im Serum gemacht. Cortisonbehandelte Tiere, mit oder ohne Thyreoidea, zeigten alle eine verminderte Knochenmasse, aber die Verminderung war in allen Parametern signifikanter in Gruppe 4. Da diese Tiere bekanntlich genügend Thyroxin aber einen Calcitoninmangel hatten, kann die verminderte Knochenmasse in der Gruppe 4 wahrscheinlich mit einer Calcitonin-Insuffizienz in Verbindung gebracht werden. Diese Beobachtungen lassen vermuten, daß endogenes CT zur Erhaltung der Knochenmasse in den Frühstadien der Nebennierenrinden-Hyperfunktion beiträgt, vermutlich indem es der Hyperaktivität der Parathyreoidea entgegenwirkt.
    Notes: Abstract Adult male New Zealand white rabbits were divided into the following groups: 1) control, no treatment; 2) cortisone acetate (CA) 5 mg/kg body weight/day intramuscularly; 3) total thyroidectomy with daily replacement of 25 μg thyroxine given intramuscularly as in Group 2; 4) total thyroidectomy with thyroxine replacement as above and CA treatment as in Group 2. After 21, 28, and 35 days of treatment, the femora and vertebral bodies were examined histologically, roentgenographically, and by determination of mass per unit volume. Ribs, femora and vertebral bodies were analyzed for total calcium, hydroxyproline, and hexosaminecollagen ratio. Serial determinations of serum calcium and inorganic phosphorus were also made. Cortisone-treated animals, intact or thyroidectomized, had decreased bone mass, but by all parameters the decrease was more significant in Group 4. Since these animals were known to be euthyroid but calcitonin-deficient, the decreased bone mass observed in Group 4 may be correlated with CT insufficiency. These observations suggest that endogenous CT contributes to the maintenance of bone mass in the early stages of hyperadrenocorticism, possibly by offsetting hyperactivity of the parathyroid gland.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...